 ABINGDON, OXFORDSHIRE ACCESSWIRE October 28, 2019 Midatech Pharma PLC MTPH.LMTP, an RD; biotechnology company focused on delivering innovative oncology and rare disease products to patients, today announced the closing of its previously announced registered direct offering of 3,000,000 of its American Depositary Shares ADSs each ADS representing 20 of the Companys ordinary shares the New Ordinary Shares at a purchase price of US1.00 per ADS equivalent to 3.9 pence per New Ordinary Share. Additionally, in a concurrent private placement, the Company issued to the Investor unregistered warrants to purchase up to 3,000,000 ADSs Warrant ADSs. 